Atreca to Present at the Cowen and Company Annual Health Care Conference

Atreca, Inc., a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, announced today that John A. Orwin, President and Chief Executive Officer, will present at the Cowen and Company 39th Annual Health Care Conference. Mr. Orwins presentation will take place on Monday, March 11, 2019, at 2:30 p.m. Eastern Daylight Time at the Boston Marriott Copley Place.

About Atreca, Inc.

Atreca is a privately held biotechnology company developing novel therapeutics based on a deep understanding of the human immune response. Atreca focuses in a unique way on the immune responses of patients in therapeutic areas where such responses are the key phenomenon driving clinical outcomes, enabling the Company to discover and develop novel immunotherapies. Atreca is advancing a pipeline of candidates designed to engage the human immune response in oncology and other indications, thus driving better therapeutic outcomes. For more information on Atreca, please visit www.atreca.com.

Atreca, Inc.
Herb Cross
Chief Financial Officer
[email protected]
or
Media:
Nancie
Steinberg, 212-213-0006, ext. 318
[email protected]
Robert
Flamm, 212-213-0006, ext. 364
[email protected]
or
Investors:
Alex
Gray, 212-213-0006, ext. 355
[email protected]

WANT TO BUILD A FINANCIAL EMPIRE?

Subscribe to the Global Banking & Finance Review Newsletter for FREE
Get Access to Exclusive Reports to Save Time & Money

By using this form you agree with the storage and handling of your data by this website. We Will Not Spam, Rent, or Sell Your Information.
All emails include an unsubscribe link. You may opt-out at any time. See our privacy policy.